Intravenous pegloticase Market by Market Report

Intravenous pegloticase Market to Witness a Healthy Growth during 2020 â&#x20AC;&#x201C; 2030 Nov 2020

Report Id : REP-GB-12462 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices @futuremarketins I /company/future-market-insights

www.futuremarketinsights.com I

ÂŠ 2019 Future Market Insights, AllI Rights/company/future-market-insights Reserved www.futuremarketinsights.com I @futuremarketins

About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.

Research Capabilities    

Customized Research Syndicated Research

Customized Research Syndicated Research Investment Research Social Media Research

Sector Coverage    

Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment

   

Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please contact

Investment Research

Hari. T (Sr. Manager - Global Business Development)

Social Media Research

Email: hari.t@futuremarketinsights.com

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights

Research Methodology (1/2) Systematic Research Approach 1 Market profiling

2 Formulating discussion guide

3 Developing list of respondents

4 Data collection

Data validation

Data analysis

Insights

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. FMI formulates a detailed discussion guide to conduct expert and industry interviews FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts FMI conducts interviews with industry experts, industry players, distributors and retailers Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry FMI delivers industry insights and information in the required format (PDF)

Data Collection

   

Research & Intelligence

Data Filter & Analysis

Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain

Actionable Insights

A Primary Research

SOLUTION 

Market participants



Key strengths



Product portfolio



Mapping as per value chain



Key focus segments



Key industry experts



Channel study



Developments

Desk Research



Market dynamics



Products



Conclusions

C Company Analysis

Primary Research #    

Business Solution

Linkedin Zoominfo Salesforce Avention

Secondary Research #  

 

Company websites Company annual reports White papers Financial reports

Paid Publications#    

Factiva GBI Genios Meltwater

# includes sources of databases

www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights

Intravenous pegloticase Market Analysis Market Overview Intravenous pegloticase is a drug used for the treatment of chronic and refractory gout disease, used for treating the patients who have undergone medications that did not work well. Gout is a disease caused due to excessive uric acid in the blood (hyperuricemia).

Intravenous pegloticase works by lowering the amount of uric acid in the body. Intravenous pegloticase is administered in healthcare settings and healthcare by healthcare providers to manage the adverse events of the drug. Intravenous pegloticase market is expected to expand during the forecast period due to the increasing prevalence of gout disease across the globe and strong R & D pipelines. Pandemic coronavirus is believed to have a severe impact on the global intravenous pegloticase market. Intravenous pegloticase market manufacturing industries are being shuttered around the world causing an unprecedented technology and business model transformation.

www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights

Intravenous pegloticase Market Analysis There has been a disruption in the production and supply of intravenous pegloticase due to the global restrictions. Also, the flow of patients seeking gout treatment in the hospitals and clinics is reduced which is affecting the global intravenous pegloticase market.

Intravenous pegloticase Market: Drivers and RestraintsThe increasing prevalence of chronic and refractory gout disease is expected to be the major driver of the intravenous pegloticase growth market. The strong R & D pipelines are another major factor driving the growth of the intravenous pegloticase market. The increasing mergers and collaborations between major companies and increasing demand for effective treatment of chronic and refractory gout are also driving the growth of the intravenous pegloticase market.

Furthermore, the rising awareness and adoption of intravenous pegloticase in the management of chronic and refractory gout disease, especially in emerging nations is likely to boost the intravenous pegloticase market growth.

www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights

Intravenous pegloticase Market Analysis However, there are some factors which can restrain the growth of the intravenous pegloticase market such as adverse reactions of the drug associated with its use, including infusion reactions, and anaphylaxis.

Many other adverse events such as gout flare, nausea, contusion, nasopharyngitis chest pain and vomiting have also been reported. Also, the stringent regulations imposed by the authorities restrict the intravenous pegloticase market growth. Intravenous pegloticase Market: Overview Based on the age group, the adult segment is expected to hold a major share in the intravenous pegloticase market due to the increasing prevalence of chronic and refractory gout disease among the adult population. Based on the indication, the chronic gout disease segment is expected to dominate the intravenous pegloticase market. Based on the distribution channel, the hospital pharmacies are expected to be the most profitable segment in the global intravenous pegloticase market due to the higher number of patients flow in the hospitals. www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights

Intravenous pegloticase Market Analysis Intravenous pegloticase Market: Region-wise Outlook North America is expected to dominate the global intravenous pegloticase market, due to the advancement in the treatment of gout diseases and increasing prevalence of chronic and refractory gout disease in the region. North America is expected to be followed by Europe, due to the higher adoption of the drug in the region.

Asia-Pacific is expected to have a significant growth in the global intravenous pegloticase market over the forecast period due to the increasing awareness of intravenous pegloticase usage, and rising healthcare expenditure. Also increasing population in countries like China and India is further likely to boost the intravenous pegloticase market growth in the region. Intravenous pegloticase Market: Key Market Participants

• Some of the market participants in the global intravenous pegloticase market identified across the value chain include: • Horizon Therapeutics • BTG plc • Savient Pharmaceuticals In www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights

Intravenous pegloticase Market Analysis Intravenous pegloticase Market Segmentation age group

• Pediatric • Adult • Geriatric

indication • Chronic • Refractory

distribution channnel Click here to Order a free sample

• Hospital pharmacies • Retail Pharmacies

For more insights on the Wound Irrigation System Market, you can request a report sample with full TOC www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights

To know more about us, please visit our website:

www.futuremarketinsights.com For sales queries or new topics email us on:

sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

Thank You Future Market Insights Global & Consulting Private Limited (FMI) www.futuremarketinsights.com I

@futuremarketins I

/company/future-market-insights